식물 유전체 공학을 위한 효율적인 표적 부위 통합을 위한 전이효소 보조 기술
식물 유전체에 새로운 DNA를 특정 위치에 삽입하는 현재 기술은 저빈도이고 오류가 많아 개선된 작물 개발을 위한 유전체 편집 접근을 방해한다. 이 연구는 전이효소의 자연스러운 삽입 능력을 활용하여 프로그래밍 가능한 방식으로 표적 삽입을 달성하는 새로운 유전체 공학 도구를 개발했다.
植物ゲノム工学のための効率的なターゲットサイト統合のためのトランスポゼース支援
トランスポゼースの自然な能力を利用して、プログラム可能なCRISPRヌクレアーゼと融合させることで、植物ゲノムへの配列特異的な挿入を可能にする。
CRISPR: 유전자 편집 기술의 혁명적인 발전
CRISPR는 박테리아의 적응 면역 시스템에서 발견된 혁신적인 유전자 편집 도구로, 염색체 DNA의 특정 부위에서 추가, 삭제 또는 수정을 가능하게 하여 유전학 및 생명 과학 분야에 큰 변화를 가져왔다.
CRISPR: A Groundbreaking Gene-Editing Tool Revolutionizing Scientific Research and Potential Applications
CRISPR is a revolutionary gene-editing tool that enables precise modifications to DNA, transforming scientific research and offering promising applications.
European Medicines Agency Approves Two Novel Therapies: Hemophilia B Gene Therapy and Enzyme Replacement for Congenital Thrombotic Thrombocytopenic Purpura
The European Medicines Agency has granted conditional marketing authorization for Durveqtix, a gene therapy for severe and moderately severe hemophilia B, and Adzynma, an enzyme replacement therapy for congenital thrombotic thrombocytopenic purpura, addressing unmet medical needs in these rare conditions.
Engineered Migrasomes: A Robust and Temperature-Stable Vaccine Platform
Engineered migrasomes (eMigrasomes) are a novel, robust, and temperature-stable vaccine platform that can effectively deliver antigens and induce potent antibody responses.
Genetic Engineering of Human Mesenchymal Stem Cell Lines to Produce Customized Extracellular Matrix Scaffolds for Tissue Regeneration
CRISPR/Cas9 can be used to genetically edit human mesenchymal stem cell lines to produce engineered extracellular matrix (eECM) scaffolds with targeted composition and function, enabling the development of customized cell-free tissue engineering solutions.
효과적인 백신 증강제를 대량 생산할 수 있는 효모 기반 기술 개발
식물에서 추출한 백신 증강제를 효모를 이용해 대량 생산할 수 있는 기술이 개발되었다.
酵母で大量生産可能な植物由来のワクチン増強剤
植物由来の分子は医薬品の重要な源泉だが、抽出や化学合成が困難な場合が多い。研究者らは、強力な植物由来ワクチン増強剤を遺伝子組み換え酵母で大量生産する方法を開発した。
Engineered Yeast Strains Produce Potent Plant-Derived Vaccine Adjuvant for Improved Immunogenicity
Engineered yeast strains can be used to efficiently produce a potent plant-derived vaccine adjuvant, overcoming the challenges of low yields and ecosystem damage associated with direct plant extraction.
- efficient-semantic-tokenization-for-deep-ctr-prediction
- advancing-security-in-ai-systems-novel-approach-to-detecting-backdoors-in-deep-neural-networks
- bg-hgnn-addressing-parameter-explosion-and-relation-collapse-in-heterogeneous-graph-neural-networks
- exploring-height-bounded-lempel-ziv-encodings-for-fast-access
- large-language-models-enhancing-reasoning-with-contrastive-prompting
- analyzing-large-language-models-for-authorship-identification
- p2lhap-wearable-sensor-based-human-activity-recognition-segmentation-and-forecasting
- implicitly-infusing-spatial-geometric-prior-knowledge-into-visual-semantic-segmentation-for-autonomous-driving
© 2024 by Linnk AI